Here, the clinical and biochemical investigations indicate that <i>ETFDH</i>:p.Pro227Thr and <i>PHGDH</i>:p.Ser407Pro variants likely underlie the pathogenesis of GA-II and serine deficiency, respectively. The gene discussed is ETFDH; the disease is neurometabolic disorder due to serine deficiency.